Search research articles
Contact Us
Filters
Showing results (241-250 of 253) with videos related to
Page
of 26
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 31, 2020
Taking One Step Back in Familial Hypercholesterolemia: <i>STAP1</i> Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans
Natalia Loaiza, Merel L Hartgers, Laurens F Reeskamp, et al.
Cancer & Metabolism
|
April 21, 2023
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
Martijn G S Rutten, Yu Lei, Joanne H Hoogerland, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 14, 2020
Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid
Jan Freark de Boer, Hilde D de Vries, Anna Palmiotti, et al.
Journal of Inherited Metabolic Disease
|
March 19, 2021
Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
Joanne A Hoogerland, Fabian Peeks, Brenda S Hijmans, et al.
NPJ Regenerative Medicine
|
March 26, 2025
Fibroblast-derived osteoglycin promotes epithelial cell repair
Luke van der Koog, Manon E Woest, Iris C Gorter, et al.
Aging Cell
|
November 10, 2017
Running-wheel activity delays mitochondrial respiratory flux decline in aging mouse muscle via a post-transcriptional mechanism
Sarah Stolle, Jolita Ciapaite, Aaffien C Reijne, et al.
Journal of Hepatology
|
June 18, 2016
Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunction
Tim van Zutphen, Jolita Ciapaite, Vincent W Bloks, et al.
Hepatology (Baltimore, Md.)
|
September 2, 2022
Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
Willemien van Zwol, Antoine Rimbert, Justina C Wolters, et al.
Hepatology (Baltimore, Md.)
|
June 23, 2022
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism
Audrey Deprince, Nathalie Hennuyer, Sander Kooijman, et al.
Circulation Research
|
November 23, 2021
Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome
Paolo Zanoni, Grigorios Panteloglou, Alaa Othman, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 253) with videos related to
Sort By:
Page
of 26
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 31, 2020
Taking One Step Back in Familial Hypercholesterolemia: <i>STAP1</i> Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans
Natalia Loaiza, Merel L Hartgers, Laurens F Reeskamp, et al.
Cancer & Metabolism
|
April 21, 2023
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
Martijn G S Rutten, Yu Lei, Joanne H Hoogerland, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 14, 2020
Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid
Jan Freark de Boer, Hilde D de Vries, Anna Palmiotti, et al.
Journal of Inherited Metabolic Disease
|
March 19, 2021
Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
Joanne A Hoogerland, Fabian Peeks, Brenda S Hijmans, et al.
NPJ Regenerative Medicine
|
March 26, 2025
Fibroblast-derived osteoglycin promotes epithelial cell repair
Luke van der Koog, Manon E Woest, Iris C Gorter, et al.
Aging Cell
|
November 10, 2017
Running-wheel activity delays mitochondrial respiratory flux decline in aging mouse muscle via a post-transcriptional mechanism
Sarah Stolle, Jolita Ciapaite, Aaffien C Reijne, et al.
Journal of Hepatology
|
June 18, 2016
Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunction
Tim van Zutphen, Jolita Ciapaite, Vincent W Bloks, et al.
Hepatology (Baltimore, Md.)
|
September 2, 2022
Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
Willemien van Zwol, Antoine Rimbert, Justina C Wolters, et al.
Hepatology (Baltimore, Md.)
|
June 23, 2022
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism
Audrey Deprince, Nathalie Hennuyer, Sander Kooijman, et al.
Circulation Research
|
November 23, 2021
Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome
Paolo Zanoni, Grigorios Panteloglou, Alaa Othman, et al.
Page
of 26